| 1 |
Álvarez García FJ, Cilleruelo Ortega MJ, Álvarez Aldeán J, Garcés-Sánchez M, Garrote Llanos E, Iofrío de Arce A, Montesdeoca Melián A, Navarro Gómez ML, Pineda Solas V, Rivero Calle I, Ruiz-Contreras J, Serrano Marchuet P; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations. An Pediatr (Engl Ed) 2023;98:58.e1-58.e10. [PMID: 36599520 DOI: 10.1016/j.anpede.2022.11.002] [Reference Citation Analysis]
|
| 2 |
Álvarez García FJ, Cilleruelo Ortega MJ, Álvarez Aldeán J, Garcés-sánchez M, Garrote Llanos E, Iofrío de Arce A, Montesdeoca Melián A, Navarro Gómez ML, Pineda Solas V, Rivero Calle I, Ruiz-contreras J, Serrano Marchuet P. Calendario de inmunizaciones de la Asociación Española de Pediatría: recomendaciones 2023. Anales de Pediatría 2023;98:58.e1-58.e10. [DOI: 10.1016/j.anpedi.2022.10.002] [Reference Citation Analysis]
|
| 3 |
Carrico J, La EM, Talbird SE, Chen YT, Nyaku MK, Carias C, Mellott CE, Marshall GS, Roberts CS. Value of the Immunization Program for Children in the 2017 US Birth Cohort. Pediatrics 2022;150:e2021056007. [PMID: 35821603 DOI: 10.1542/peds.2021-056007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 4 |
Talbird SE, Carrico J, La EM, Carias C, Marshall GS, Roberts CS, Chen YT, Nyaku MK. Impact of Routine Childhood Immunization in Reducing Vaccine-Preventable Diseases in the United States. Pediatrics 2022;150:e2021056013. [PMID: 35821599 DOI: 10.1542/peds.2021-056013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 5 |
Burke RM, Groom HC, Naleway AL, Katz EM, Salas B, Mattison CP, Donald J, Tsaknaridis L, Biggs C, Bowen MD, Tate JE, Parashar UD, Schmidt M, Hall AJ. Rotavirus Vaccine Is Effective Against Rotavirus Gastroenteritis Resulting in Outpatient Care: Results From the Medically Attended Acute Gastroenteritis (MAAGE) Study. Clin Infect Dis 2021;72:2000-5. [PMID: 32322882 DOI: 10.1093/cid/ciaa466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Gönüllü E, Soysal A, Yıldız İ, Karaböcüoğlu M. Impact of self-financed rotavirus vaccination on acute gastroenteritis in young children in Turkey. Hum Vaccin Immunother 2021;17:510-6. [PMID: 32702249 DOI: 10.1080/21645515.2020.1776043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Jenney AWJ, Reyburn R, Ratu FT, Tuivaga E, Nguyen C, Covea S, Thomas S, Rafai E, Devi R, Bright K, Jenkins K, Temple B, Tikoduadua L, Kado J, Mulholland EK, Kirkwood CD, Fox KK, Bines JE, Grabovac V, Khan AS, Kama M, Russell FM. The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji. Lancet Reg Health West Pac 2021;6:100053. [PMID: 34327400 DOI: 10.1016/j.lanwpc.2020.100053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 8 |
Cho H, Lee H, Kim DS, Kim HM, Kim JH, Kim AY, Kang HY. Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines. Pediatr Infect Dis J 2020;39:460-5. [PMID: 31990891 DOI: 10.1097/INF.0000000000002582] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 9 |
Bruijning-Verhagen P, van Dongen JAP, Verberk JDM, Pijnacker R, van Gaalen RD, Klinkenberg D, de Melker HE, Mangen MJ. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting. BMC Med 2018;16:168. [PMID: 30196794 DOI: 10.1186/s12916-018-1134-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 10 |
Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact. Expert Review of Vaccines 2018;17:593-606. [DOI: 10.1080/14760584.2018.1489724] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 11 |
Krishnarajah G, Kageleiry A, Korves C, Lefebvre P, Duh MS. Public health impact of Rotarix vaccination among commercially insured children in the United States. Vaccine 2017;35:5065-72. [DOI: 10.1016/j.vaccine.2017.06.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 12 |
Gervasi G, Capanna A, Mita V, Zaratti L, Franco E. Nosocomial rotavirus infection: An up to date evaluation of European studies. Hum Vaccin Immunother 2016;12:2413-8. [PMID: 27185183 DOI: 10.1080/21645515.2016.1183858] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 13 |
Calnan M, Krishnarajah G, Duh MS, Haider BA, Yermakov S, Davis M, Yan S. Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance. Hum Vaccin Immunother 2016;12:1235-43. [PMID: 26900728 DOI: 10.1080/21645515.2015.1136041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
